Form 4: Abbott Laboratories Director Acquires Shares and Restricted Stock Units

Director Darren W. McDew acquired 1,635 common shares and restricted stock units in Abbott Laboratories on April 25, 2025.

Summary

• On April 25, 2025, Darren W. McDew, a director of Abbott Laboratories, acquired 1,635 common shares without par value.
• These shares were acquired at a price of $0.
• McDew also acquired restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program.
• These restricted stock units will be paid in Abbott common shares on a one-to-one basis upon separation from service, death, or a change in control.
• Following the reported transactions, McDew beneficially owns 10,392 common shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares and restricted stock units suggests confidence in the company, but it's a routine transaction.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the acquisition of shares and restricted stock units suggests a continued alignment of the director's interests with the company's performance.

Industry Context

Director share acquisitions are common in publicly traded companies and are often viewed as a sign of confidence in the company's prospects. This filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates

Keywords

Abbott Laboratories, Director, Share Acquisition, Restricted Stock Units, Beneficial Ownership, Form 4, ABT